Categories: News

MEDIROM Healthcare Technologies Inc. Announces May 2022 Key Performance Indicators (KPIs)

Total Customers Served: 77,291 – Sales Per Customer: JPY 6,461 – Customer Repeat Ratio: 79.6%

May 2022_Number of Salons

May 2022_Number of Salons

May 2022_Total Customers Served

May 2022_Total Customers Served

May 2022_Sales per Customer

May 2022_Sales per Customer

May 2022_Repeat Ratio

May 2022_Repeat Ratio

NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of May 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.

The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of May 2022.

  • The number of salons was 308 in May 2022, down from 313 in the year-ago period.
  • Total customers served increased to 77,291 in May 2022 from 66,604 in the year-ago period. The increase is primarily attributed to the increase in the number of salons with available financial and customer data, and the recovery from the impact of COVID-19.
  • Sales per customer increased to JPY6,461 in May 2022, up from JPY6,370 in May 2021. The increase is attributed to the upselling of value-added optional services.
  • Our repeat ratio, a measure of repeat customers, decreased to 79.6% in May 2022 from 80.6% in the year-ago period.
  • Our operation ratio increased to 50.1% in May 2022 from 48.7% in the year-ago period. The increase is primarily attributed to the increase in the total customers served.
  • The total number of salons with data increased to 232 in March 2022 from 212 in March 2021. The increase is attributed to the completion of the replacement of the customer management system in certain salons. The number of salons with data decreases when we close salons with data available and increases as we open salons with such data.
  Number of Salons(*1) Number of Salons with Data(*2) Total Customers Served(*3) Sales per Customer(*4) Repeat Ratio(*5) Operation Ratio(*6)
May-21 313 212 66,604 JPY 6,370 80.6% 48.7%
June-21 313 219 68,069 JPY 6,350 81.2% 48.6%
July-21 314 220 70,912 JPY 6,498 81.0% 48.1%
August-21 315 221 66,323 JPY 6,592 81.3% 46.5%
September-21 316 221 65,130 JPY 6,428 82.0% 46.7%
October-21 316 221 68,608 JPY 6,486 83.3% 48.9%
November-21 316 221 65,569 JPY 6,466 81.9% 47.7%
December-21 312 221 71,173 JPY 6,634 81.7% 50.5%
January-22 312 221 62,747 JPY 6,570 82.4% 48.2%
February-22 310 219 54,443 JPY 6,662 83.8% 46.4%
March-22 310 217 61,417 JPY 6,595 82.4% 46.5%
April-22 309 232 69,986 JPY 6,616 82.0% 48.3%
May-22 308 232 77,291 JPY 6,461 79.6% 50.1%

(*1) Number of Salons: Includes our directly-operated salons, and franchisees’ salons.
(*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.
(*3) Total Customers Served: The number of customers served at salons for which comparative financial and customer data is available.
(*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.
(*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.
(*6) Operation Ratio: The ratio of therapists’ in-service time to total therapists’ working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.

*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.

About MEDIROM Healthcare Technologies Inc.
MEDIROM a holistic healthcare company, operates 308 (as of May 31, 2022) relaxation salons across Japan, Re.Ra.Ku®, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called “Lav®”, which is developed by the company. MEDIROM also entered the device business in 2020 and is developing a smart tracker “MOTHER Bracelet” (formerly known as “MOTHER Tracker®”). MEDIROM hopes that its diverse health related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en

Forward-Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/371210b7-87cd-41c8-bd83-6bc362535143

https://www.globenewswire.com/NewsRoom/AttachmentNg/5e05c8a5-a088-40f7-a5f2-15247bf1cf5c

https://www.globenewswire.com/NewsRoom/AttachmentNg/b4b4f57f-e810-41ec-9086-ca589aa8ea5d

https://www.globenewswire.com/NewsRoom/AttachmentNg/11360dfe-8fbd-4fbf-8b37-7c4b9aacf7fa

https://www.globenewswire.com/NewsRoom/AttachmentNg/22086c67-0c4e-4845-9fa9-6c1fa4a00566

CONTACT: Contacts
Investor Relations Team
ir@medirom.co.jp
Or
U.S. Investor Contact
Robert Blum, Joe Diaz, Joe Dorame
Lytham Partners, LLC
602-889-9700
MRM@lythampartners.com

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

2 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

3 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

3 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

4 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago